Abstract
QUESTION: Several of my female patients take bisphosphonates for low bone mineral density (BMD). Two of them are of reproductive age. Are these drugs safe during pregnancy? ANSWER: Very little is currently known about the effects of bisphosphonates on human pregnancy. There have been only two reports of bisphosphonate use during late pregnancy. Animal studies suggest that biphosphonates cross the placenta and that the effect is an extension of the expected pharmacologic effect of bisphosphonates on both fetus and mother. Risks and benefits should be carefully weighed.
Full Text
The Full Text of this article is available as a PDF (96.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dunlop D. J., Soukop M., McEwan H. P. Antenatal administration of aminopropylidene diphosphonate. Ann Rheum Dis. 1990 Nov;49(11):955–955. doi: 10.1136/ard.49.11.955-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Graepel P., Bentley P., Fritz H., Miyamoto M., Slater S. R. Reproduction toxicity studies with pamidronate. Arzneimittelforschung. 1992 May;42(5):654–667. [PubMed] [Google Scholar]
- Illidge T. M., Hussey M., Godden C. W. Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pamidronate. Clin Oncol (R Coll Radiol) 1996;8(4):257–258. doi: 10.1016/s0936-6555(05)80667-3. [DOI] [PubMed] [Google Scholar]
- Minsker D. H., Manson J. M., Peter C. P. Effects of the bisphosphonate, alendronate, on parturition in the rat. Toxicol Appl Pharmacol. 1993 Aug;121(2):217–223. doi: 10.1006/taap.1993.1148. [DOI] [PubMed] [Google Scholar]
- Okazaki A., Matsuzawa T., Takeda M., York R. G., Barrow P. C., King V. C., Bailey G. P. Intravenous reproductive and developmental toxicity studies of cimadronate (YM175), a novel bisphosphonate, in rats and rabbits. J Toxicol Sci. 1995 Oct;20 (Suppl 1):1–13. doi: 10.2131/jts.20.supplementi_1. [DOI] [PubMed] [Google Scholar]
- Patlas N., Golomb G., Yaffe P., Pinto T., Breuer E., Ornoy A. Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology. 1999 Aug;60(2):68–73. doi: 10.1002/(SICI)1096-9926(199908)60:2<68::AID-TERA10>3.0.CO;2-H. [DOI] [PubMed] [Google Scholar]
- Sakiyama Y., Tada I., Yamamoto H., Nakanishi T., Yasuda Y., Soeda Y., Oda M. The effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) on fetal mice during pregnancy--with emphasis on implantation and fetal weight. J Osaka Dent Univ. 1986 Oct;19(2):87–90. [PubMed] [Google Scholar]
- Siminoski K., Fitzgerald A. A., Flesch G., Gross M. S. Intravenous pamidronate for treatment of reflex sympathetic dystrophy during breast feeding. J Bone Miner Res. 2000 Oct;15(10):2052–2055. doi: 10.1359/jbmr.2000.15.10.2052. [DOI] [PubMed] [Google Scholar]